Trends in hospital price transparency after implementation of the CMS Final Rule.

Autor: Brant A; Department of Urology, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA., Lewicki P; Department of Urology, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA., Rhodes S; Department of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA., Zhu A; Department of Urology, New York-Presbyterian Hospital, Weill Cornell Medical College, New York, New York, USA., Shoag J; Department of Urology, University Hospitals Cleveland Medical Center, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Jazyk: angličtina
Zdroj: Health services research [Health Serv Res] 2024 Aug; Vol. 59 (4), pp. e14329. Date of Electronic Publication: 2024 May 28.
DOI: 10.1111/1475-6773.14329
Abstrakt: Objective: To assess trends in hospital price disclosures after the Centers for Medicare & Medicaid Services (CMS) Final Rule went into effect.
Data Sources and Study Setting: The Turquoise Health Price Transparency Dataset was used to identify all US hospitals that publicly displayed pricing from 2021 to 2023.
Study Design: Price-disclosing versus nondisclosing hospitals were compared using Pearson's Chi-squared and Wilcoxon rank sum tests. Bayesian structural time-series modeling was used to determine if enforcement of increased penalties for nondisclosure was associated with a change in the trend of hospital disclosures.
Data Collection/extraction Methods: Not applicable.
Principal Findings: As of January 2023, 5162 of 6692 (77.1%) US hospitals disclosed pricing of their services, with the majority (2794 of 5162 [54.1%]) reporting their pricing within the first 6 months of the final rule going into effect in January 2021. An increase in hospital disclosures was observed after penalties for nondisclosure were enforced in January 2022 (relative effect size 20%, p = 0.002). Compared with nondisclosing hospitals, disclosing hospitals had higher annual revenue, bed number, and were more likely to be have nonprofit ownership, academic affiliation, provide emergency services, and be in highly concentrated markets (p < 0.001).
Conclusions: Hospital pricing disclosures are continuously in flux and influenced by regulatory and market factors.
(© 2024 Health Research and Educational Trust.)
Databáze: MEDLINE
Externí odkaz: